Clinical Trial Update: Study to Compare the Efficacy and Safety of QVM149 With QMF149 in Patients With Asthma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing QVM149 with QMF149 in asthma has completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• QMF149 (mometasone/formoterol)
• QVM149 (Indacaterol acetate / glycopyrronium bromide / mometasone furoate)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2020-07-22